Can I Take Vitamin B12 with Losartan?

Why This Question Comes Up So Often

Losartan is one of the most widely prescribed angiotensin II receptor blockers (ARBs) in the United States, with over 50 million dispensed prescriptions annually according to ClinCalc drug usage statistics. Patients taking it for hypertension, heart failure, or diabetic nephropathy often also take vitamin B12 supplements. The question of safety between the two surfaces repeatedly in pharmacy consultations and online health forums.

The Overlap with Metabolic Disease

The concern is not unfounded, but the risk is misattributed. Losartan itself does not interfere with B12 absorption, metabolism, or function. The confusion typically stems from the fact that many losartan users also take metformin for type 2 diabetes. Metformin is the drug that depletes B12 [1]. When patients search for "losartan and B12," they are often managing a multi-drug regimen where the actual culprit is metformin, not losartan.

Who Should Pay Attention

If you take losartan alone for blood pressure, B12 supplementation carries no special risk. If you take losartan as part of a cardiometabolic regimen that includes metformin, B12 monitoring becomes clinically important. The distinction matters.

Direct Interaction Profile: Losartan and Vitamin B12

No published evidence in PubMed, the Natural Medicines Comprehensive Database, or the Mayo Clinic drug interaction checker identifies a direct interaction between losartan and vitamin B12. This absence of signal spans pharmacokinetic, pharmacodynamic, and clinical outcome data.

Pharmacokinetic Analysis

Losartan is metabolized primarily by CYP2C9 and CYP3A4 in the liver, converting the parent drug to its active metabolite EXP-3174, which is 10 to 40 times more potent as an angiotensin II receptor antagonist. Vitamin B12 (cyanocobalamin or methylcobalamin) does not undergo hepatic CYP450 metabolism. It is absorbed in the ileum via intrinsic factor binding and distributed through transcobalamin II carrier proteins [2]. These two compounds occupy entirely separate metabolic pathways.

Pharmacodynamic Analysis

Losartan blocks the AT1 receptor, reducing aldosterone secretion, lowering peripheral vascular resistance, and decreasing sodium reabsorption. Vitamin B12 functions as a cofactor for methionine synthase and methylmalonyl-CoA mutase. It plays no role in the renin-angiotensin-aldosterone system. There is no receptor-level, enzyme-level, or signaling-pathway overlap between these two substances.

What the Databases Say

The Natural Medicines Comprehensive Database does not list losartan as a drug that interacts with vitamin B12 at any severity level. The FDA prescribing label for losartan (Cozaar) does not mention B12 among its drug interactions [3]. This is as close to a clean bill as pharmacology offers.

The Metformin-B12 Depletion Connection

The clinically significant issue for many losartan users is not losartan itself but the metformin they take alongside it. This is where B12 supplementation shifts from optional to recommended.

How Metformin Depletes B12

Metformin reduces vitamin B12 absorption in the terminal ileum by interfering with the calcium-dependent binding of the intrinsic factor-B12 complex to cubilin receptors. A landmark study published in the BMJ in 2010 (N=390) found that metformin use for 4.3 years reduced serum B12 by 19% compared to placebo, with 7.2% of metformin users developing B12 levels below 150 pmol/L versus 2.3% on placebo [4].

The Diabetes Prevention Program Outcomes Study (DPPOS) confirmed these findings at scale. Among 2,155 participants randomized to metformin, long-term use was associated with a higher prevalence of biochemical B12 deficiency. The American Diabetes Association (ADA) now recommends periodic B12 measurement in patients on long-term metformin, particularly those with anemia or peripheral neuropathy [5].

Why This Matters for Losartan Users

Losartan carries a specific FDA-approved indication for diabetic nephropathy in patients with type 2 diabetes and hypertension, based on the RENAAL trial (N=1,513), which demonstrated a 16% reduction in the composite endpoint of doubling of serum creatinine, end-stage renal disease, or death [6]. Patients on losartan for this indication are, by definition, diabetic. A large proportion of them also take metformin. This creates a population where B12 monitoring is genuinely important, even though losartan is not the cause.

Clinical Consequences of Untreated B12 Deficiency

B12 deficiency is not a benign laboratory finding. Left uncorrected, it produces hematologic and neurologic damage that may be irreversible.

Megaloblastic Anemia

B12 deficiency impairs DNA synthesis in rapidly dividing cells, most notably erythrocyte precursors. The result is megaloblastic anemia, characterized by macrocytic red blood cells (MCV >100 fL), fatigue, and pallor. A complete blood count (CBC) showing elevated MCV in a patient on metformin should prompt B12 testing before attributing the finding to other causes [7].

Peripheral Neuropathy

This is the more dangerous consequence. B12 deficiency causes demyelination of peripheral nerves, producing numbness, tingling, and burning in the distal extremities. In diabetic patients, this presentation is clinically indistinguishable from diabetic peripheral neuropathy [8]. A 2019 cross-sectional study in Diabetes Care (N=1,260) found that metformin-treated patients with low B12 had significantly higher neuropathy scores compared to those with normal B12 levels, independent of HbA1c and diabetes duration [9].

Cognitive Effects

Severe or prolonged B12 deficiency is associated with cognitive decline, particularly in older adults. A meta-analysis of 43 studies published in JAMA Neurology found that low serum B12 was associated with a 21% increased risk of cognitive impairment and a 17% increased risk of Alzheimer disease [10]. For patients already managing cardiovascular and metabolic disease, adding cognitive decline to the symptom burden is avoidable with simple supplementation.

Recommended B12 Supplementation Protocol

For patients taking losartan without metformin, there is no pharmacologic reason to supplement B12 beyond general nutritional adequacy. For those on losartan plus metformin, structured supplementation is warranted.

Dosing

Oral cyanocobalamin at 1,000 mcg daily corrects and prevents metformin-associated B12 deficiency in the majority of patients. A randomized controlled trial (N=90) published in BMC Pharmacology and Toxicology showed that 1,000 mcg daily of oral B12 for 12 weeks raised serum B12 by a mean of 186 pmol/L in metformin users [11]. Methylcobalamin at the same dose is an acceptable alternative, though head-to-head data comparing the two forms in this population remain limited.

Timing

No dose-separation window between losartan and B12 is required. They do not compete for absorption sites, transporters, or metabolic enzymes. Patients can take both at the same time of day without concern for reduced efficacy of either compound.

Food Considerations

B12 absorption from supplements is generally efficient on an empty or full stomach. For patients also taking losartan with food (as many prescribers recommend for GI tolerance), co-administration with a meal is fine.

Monitoring Strategy

Baseline Testing

Any patient starting metformin alongside losartan should have a baseline serum B12 level drawn. The normal reference range is 200 to 900 pg/mL (148 to 664 pmol/L). Levels below 200 pg/mL warrant supplementation and further evaluation [12].

Functional Markers

Serum B12 alone can miss early deficiency. Methylmalonic acid (MMA) is a more sensitive marker. Elevated MMA (>0.4 μmol/L) in the setting of low-normal B12 (200 to 300 pg/mL) indicates tissue-level deficiency and should trigger supplementation [13]. Homocysteine is also elevated in B12 deficiency but is less specific because folate deficiency and renal impairment also raise it.

Ongoing Surveillance

The ADA's Standards of Medical Care in Diabetes recommends checking serum B12 annually in patients on long-term metformin, particularly those with symptoms of neuropathy or macrocytosis [5]. For patients on losartan without metformin, routine B12 monitoring is not necessary unless dietary deficiency is suspected (strict vegan diet, pernicious anemia risk, gastric surgery history).

Special Populations

Older Adults on Losartan and Metformin

Adults over 65 are at dual risk: age-related decline in intrinsic factor production reduces B12 absorption, and metformin compounds the problem. The Framingham Offspring Study found that 39% of adults aged 67 to 96 had serum B12 levels below 350 pg/mL, a threshold some experts consider suboptimal [14]. For older patients on both losartan and metformin, B12 supplementation at 1,000 mcg daily should be considered standard practice, not optional.

Patients with Chronic Kidney Disease

Losartan is frequently used in CKD stages 2 through 4 for its nephroprotective effects. CKD alters B12 metabolism in complex ways. Serum B12 may appear falsely normal or elevated due to reduced renal clearance of haptocorrin-bound B12 (the inactive fraction). In these patients, MMA is a more reliable marker [15]. Clinicians should not assume adequate B12 status based on serum levels alone in CKD populations.

Patients on Proton Pump Inhibitors

Many hypertensive patients on losartan also take proton pump inhibitors (PPIs) for gastroesophageal reflux. Long-term PPI use (>2 years) is independently associated with B12 deficiency, as gastric acid is required to release protein-bound B12 from food. A Kaiser Permanente study (N=25,956) found that PPI use for 2+ years was associated with a 65% increased risk of B12 deficiency compared to nonuse [16]. Stacking metformin and a PPI together creates a compounded depletion risk.

What to Do If You Are Already Taking Both

If you are currently taking losartan and vitamin B12, you can continue without modification. There is no safety signal requiring you to stop either. If you are also on metformin, take these steps:

Ask your prescriber to check serum B12 and methylmalonic acid at your next lab draw. If B12 is below 300 pg/mL or MMA is elevated, start oral B12 at 1,000 mcg daily. Recheck levels in 3 to 6 months to confirm repletion. If neurologic symptoms are present (numbness, tingling, balance problems), intramuscular B12 injections (1,000 mcg weekly for 4 weeks, then monthly) may achieve faster repletion than oral supplementation [17].

Do not discontinue losartan or metformin because of a B12 finding. Both drugs have strong outcome data supporting their continued use. B12 supplementation is the fix, not drug discontinuation.